基于基因调控网络分析的三阴性乳腺癌的潜在治疗标:全面的系统生物学方法
Maryam Ahmadi1, Neda Barkhoda1, Aida Alizamir2
1Clinical Research Development Unit of Fatemiyeh Hospital, Department of Gynecology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
这项研究确定了CHEK1和PLK1作为攻击性三阴性乳腺癌 (TNBC) 的关键基因. 它们的过度表达表明它们可能是改善TNBC治疗结果的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 系统生物学 系统生物学
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有有限治疗策略的侵袭性乳腺癌亚型.
- 确定新的治疗点对于改善TNBC患者的治疗结果至关重要.
研究的目的:
- 通过系统生物学方法确定三阴性乳腺癌 (TNBC) 的潜在治疗点.
- 分析基因调节网络,并确定TNBC病变发生的关键分子参与者.
主要方法:
- 使用GSE38959数据集对TNBC与正常乳腺组织的基因表达差异分析.
- 构建蛋白质-蛋白质相互作用网络并识别枢纽基因 (CHEK1,PLK1).
- 基因监管网络分析以确定上游监管机构 (GABPB1,JUN) 和使用GSE58135.5进行跨平台验证.
主要成果:
- 在TNBC中鉴定了943个差异表达基因 (DEGs).
- CHEK1和PLK1作为中央枢纽基因出现,过度表达与预后不佳有关.
- 确定了GABPB1和JUN作为主要的上游监管机构,并在数据集中验证了这些发现.
结论:
- CHEK1,PLK1及其上游调节器是TNBC的潜在治疗点.
- 这项研究提供了对TNBC背后的分子机制的见解.
- 针对这些途径的进一步研究可能会导致TNBC的新型治疗策略.
更多相关视频
10:36Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
相关概念视频
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
